BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35959623)

  • 1. Identification and Validation of Co-Expressed Immune-Related Gene Signature Affecting the Pattern of Immune Infiltrating in Esophageal Cancer.
    Cheng R; Zeng H; Chen L; Zhou L; Dong B
    Comb Chem High Throughput Screen; 2023; 26(4):756-768. PubMed ID: 35959623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer.
    Zeng H; Huang Y; Chen L; Li H; Ma X
    Int Immunopharmacol; 2020 Aug; 85():106622. PubMed ID: 32485354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma.
    Feng Z; Qu J; Liu X; Liang J; Li Y; Jiang J; Zhang H; Tian H
    Sci Rep; 2021 Aug; 11(1):16696. PubMed ID: 34404882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma.
    Shi X; Li Y; Pan S; Liu X; Ke Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H
    Sci Rep; 2022 Feb; 12(1):1960. PubMed ID: 35121801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma.
    Ma C; Luo H
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognosis model for predicting immunotherapy response of esophageal cancer based on oxidative stress-related signatures.
    Guo J; Tong C; Shi J; Li X; Chen X
    Oncol Res; 2023; 32(1):199-212. PubMed ID: 38196829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Key Modules and Hub Genes Involved in Esophageal Squamous Cell Carcinoma Tumorigenesis Using WCGNA.
    Chen N; Zhang G; Fu J; Wu Q
    Cancer Control; 2020; 27(1):1073274820978817. PubMed ID: 33345608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
    Jin D; Yuan L; Li F; Wang S; Mao Y
    BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy.
    Li C; Song W; Zhang J; Luo Y
    Front Immunol; 2023; 14():1322147. PubMed ID: 38098487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell mapping of N6-methyladenosine in esophageal squamous cell carcinoma and exploration of the risk model for immune infiltration.
    Nie Y; Yao G; Xu X; Liu Y; Yin K; Lai J; Li Q; Zhou F; Yang Z
    Front Endocrinol (Lausanne); 2023; 14():1155009. PubMed ID: 37025404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential core genes in esophageal carcinoma using bioinformatics analysis.
    Yang X; Tian M; Zhang W; Chai T; Shen Z; Kang M; Lin J
    Medicine (Baltimore); 2021 Jul; 100(27):e26428. PubMed ID: 34232175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
    Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
    Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEOX2 serves as a novel biomarker associated with macrophage infiltration in oesophageal squamous cell carcinoma and other digestive system carcinomas.
    Wang Z; Yang H; Zhang R; Luo B; Xu B; Zhu Z; Lin P
    Autoimmunity; 2021 Sep; 54(6):373-383. PubMed ID: 34160343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma.
    Ye Z; Fang J; Wang Z; Wang L; Li B; Liu T; Wang Y; Hua J; Wang F; Fu Z
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32662828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minichromosome maintenance 6 complex component identified by bioinformatics analysis and experimental validation in esophageal squamous cell carcinoma.
    Li X; Ren Z; Xiong C; Geng J; Li Y; Liu C; Ren C; Liu H
    Oncol Rep; 2020 Sep; 44(3):987-1002. PubMed ID: 32583000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.